Top Analyst Reports for Eli Lilly, Marriott & Fortinet

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• GSI Technology's Gemini-II processor demonstrated superior power efficiency in edge AI benchmarks

  80% confidence

• Stiff competition from Cisco Systems and Check Point Software poses concerns for Fortinet

  80% confidence

• Dolby continues to see strong engagement across its ecosystem of creators, distributors and device OEMs, but macroeconomic weakness and stiff competition remain a concern

  80% confidence

• Demand for Eli Lilly's GLP-1 drugs Mounjaro and Zepbound remains strong, making them the company's key top-line drivers

  80% confidence

• Marriott's luxury properties continued to outperform on the back of healthy demand and favorable rates

  80% confidence

• Kewaunee Scientific's consistently strong backlog provides revenue visibility and resilience

  80% confidence

• The Itiviti acquisition has boosted Broadridge's global technology and operations segment, but low liquidity is concerning

  80% confidence

• Rising R&D costs, widening operating losses and reliance on early-stage government projects present notable execution challenges for GSI Technology

  80% confidence

• For Q1 2026, Fortinet guided EPS of $0.59-$0.63 on revenue of $1.70-$1.76 billion

  80% confidence

• Old Dominion is benefiting from shareholder-friendly measures, but high capital expenditures are concerning

  80% confidence

• GSI Technology is well-funded to scale R&D and product rollout with $70.7 million in cash and no debt

  80% confidence

• Roku benefits from increased user engagement on The Roku Channel and the popularity of the Roku TV program

  80% confidence

• Hexcel Corporation is likely to benefit from improving air traffic, yet labor shortage may impact operating results

  80% confidence

• Fortinet is benefiting from strength in demand from large enterprise customers and growth in security subscriptions amid a slowdown in networking products

  80% confidence

• Challenging macroeconomic conditions and high debt levels are a concern for Marriott

  80% confidence

• GSI Technology is targeting high-growth sectors like drones and mobile robotics with AI chips optimized for low-latency and low-power environments

  80% confidence

• BILL Holdings is likely to gain from its diversified business model, expansions into the SMB ecosystem and the adoption of its AI-powered platform despite competition

  80% confidence

• Fortinet's dominant 50%+ firewall market share and extensive innovation portfolio of 1,400 global patents, including 500 AI-related innovations are expected to remain key growth drivers

  80% confidence

• Kewaunee Scientific's diversified exposure across life sciences, healthcare, education, and government markets reduces cyclicality

  80% confidence

• Marriott is benefiting from higher RevPAR, solid rooms growth and continued development momentum

  80% confidence

• Declining sales of Trulicity, rising pricing pressure on some drugs and potential competition in the GLP-1 market are top-line headwinds for Eli Lilly

  80% confidence

• Conagra has been facing pressure from soft volume trends and unfavorable shipment timing. Volume declined 3% in Q2 fiscal 2026, weighing on organic sales

  80% confidence

• Full-year 2026 guidance calls for EPS of $2.94-$3.00 on revenue of $7.50-$7.70 billion

  80% confidence

• AngioDynamics' NanoKnife traction and robust product portfolio fuel optimism, though macroeconomic uncertainty may temper near-term demand

  80% confidence

• Monolithic Power Systems will benefit from solid traction in the Automotive, Enterprise Data Storage and Computing segment

  80% confidence

• A projected increase in EOG's operating costs and soft crude prices are expected to impact the company's profit margins and cash flows in the near term

  80% confidence

• Principal Financial is set to grow on solid retirement business in Latin America and Asia as well as group benefits and protection in the US

  80% confidence

• Goodyear Forward transformation initiative is expected to deliver significant benefits in 2026, but high debt-to-capital ratio remains a concern

  80% confidence

• Robust growth trends in the U.S. incretin market and positive uptake trends in new international markets led to strong sales growth in 2025, with the positive trend expected to continue in 2026

  80% confidence

• Eli Lilly's other new drugs like Kisunla, Omvoh and Jaypirca are contributing to top-line growth

  80% confidence

Cited in these Via News reports

• Automation Slashes 200,000 Work Hours at US Bank as Global Insurers Report Surging Book Values →
• Fairfax Raises C$650M as Global Insurers Refinance Debt Amid Sector Consolidation →
• Global AI Chip Shortage Reaches 3-4% as Memory Prices Surge, New Competitors Challenge Nvidia →
• Global Insurers Report 14% Book Value Growth as Firms Signal Earnings Peak Has Passed →
• Markel Spends $919M on State National as Global Insurers Deploy $35B+ in Strategic Capital →
• Nordic Insurer OP Pohjola Flags Profit Drop While Fairfax Raises C$650M for Global M&A Push →